Clinical Trial: Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases

U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07202273) titled 'Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases' on Sept. 23.

Brief Summary: The goal of this study is to provide proof that patients can be treated with simulation-free, single-fraction palliative radiation therapy with a single in-person visit.

Study Start Date: Oct., 2025

Study Type: INTERVENTIONAL

Condition: Bone Metastases

Intervention: RADIATION: simulation-free, single-fraction palliative radiation therapy

Radiation will be delivered in a single fraction. The recommended prescription dose is 8 Gy with external beam radiation therapy.

Recruitment Status: NOT_YET_RECRUITING...